Coronavirus: Commission boosts urgently needed research and innovation with additional €122 million
25/05/2020
- Repurposing of manufacturing for vital medical supplies and equipment (€23 million)
- Medical technologies, Digital tools and Artificial Intelligence analytics to improve surveillance and care at high Technology Readiness Levels (€56 million)
- Behavioural, social and economic impacts of the outbreak responses (€20 million)
- Pan-European COVID-19 cohorts (€20 million)
- Collaboration of existing EU and international cohorts of relevance to COVID-19 (€3 million)
Please find further information on the EU-funded research and innovation actions to fight the coronavirus here.
Read more about the background of this call for expression of interest on the website of the European Commission.
Contact at BayFOR
Dr Mikhail Antonkin (Antonkine)
Scientific Officer Health research & Biotechnology
Phone: +49 (0)911 50715-950
Email: antonkin@bayfor.org


